The present authors carried out an open-label pilot analyze that administered psilocybin to 15 therapy-resistant tobacco/nicotine-dependent smokers, in the context of cognitive behavioral therapy for smoking cessation [58]. Contributors were administered ~0.29 mg/kg oral psilocybin on the participant’s concentrate on day to Give up smoking cigare